Steven Richeimer, MD
Pain Medicine · Los Angeles, CANPI 1386685584
Payments from drug & device makers
Across 21 payments — averaging $504.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$6K
- Lilly USA, LLC$3K
- Abbott$618
- Medtronic$237
- Nalu Medical, Inc.$184
- Boston Scientific$156
- plus $372 from 3 others
What the payments were for
- Consulting fees$9,02585%
- Food & beverage$9499%
- Education$6186%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 2 | $6,175 |
| Lilly USA, LLC | 1 | $2,850 |
| Abbott | 2 | $618 |
| Medtronic | 9 | $237 |
| Nalu Medical, Inc. | 3 | $184 |
| Boston Scientific | 1 | $156 |
| SPR Therapeutics, Inc | 1 | $144 |
| Avanos Medical | 1 | $141 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $88 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,592 in reported general payments places this provider in the 80th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 18 | $12,628 |
| Lidocaine | 28 | $3,476 |
| Pregabalin | 57 | $2,112 |
| Gabapentin | 67 | $1,847 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 45 | $1,066 |
| Duloxetine Hcl | 28 | $929 |
| Baclofen | 39 | $911 |
| Methadone Hcl | 37 | $682 |
| Celecoxib | 27 | $662 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 32 | $508 |
| Diclofenac Sodium | 11 | $484 |
| Tizanidine Hcl | 25 | $471 |
| Methocarbamol | 17 | $431 |
| Mirtazapine | 12 | $337 |
| Trazodone Hcl | 35 | $269 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Los Angeles
- Francis FerranteLos Angeles$75K
- Eric GrigsbyNapa$3.2M
- Jason PopeSanta Rosa$2.8M
- Javid GhandehariSanta Monica$2.7M
- Alexander HerselThousand Oaks$2.1M
- Krishnan ChakravarthyTemecula$1.9M
- Kasra AmirdelfanWalnut Creek$1.7M
- Ramana NaiduLarkspur$1.6M
- Foead GeulaStudio City$1.3M
- Xiang QianRedwood City$941K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.